Oxidative Stress and Inflammation in Health and Diseases
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: closed (30 November 2020) | Viewed by 156075
Special Issue Editor
2. Department of Ophthalmology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
Interests: neuroprotection; retina; vision; oxidative stress; inflammation; aging; age-related macular degeneration; diabetic retinopathy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advances in medical science have revealed the impact of oxidative stress and inflammation on health disorders. In particular, aging and age-related diseases may deeply relate to the interaction between oxidative stress and inflammation. The interaction could start while the people still do not have any symptoms, and under predisease conditions, or after diagnosis. Therefore, treatments for suppressing oxidative stress and/or inflammation may have effects on suppressing the interaction, which preserves healthy conditions or prevent disease progression. Therefore, to elucidate the underlying pathogenesis and expected mechanisms of the treatments would be of value.
In this Special Issue, we aim to collect both experimental research which clarifies the mechanisms which may help proceed to clinical application, and clinical research including interventional or observational studies which will stimulate the basic researchers to find topics for future research. Papers which promote the movement of “Bench to bedside, and bedside to bench” will be welcome.
Dr. Yoko Ozawa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Molecular mechanisms
- Biomarkers
- Clinical interventions
- Aging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.